aspirin has been researched along with ah 23848 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lane, IF; Lumley, P; McCollum, CN; Michael, MF; Peters, AM | 1 |
Irwin, JT; Lane, IF; McCollum, CN; Peters, AM; Sinclair, M | 1 |
Lane, I; McCollum, C; Meek, A; Poskitt, K | 1 |
2 trial(s) available for aspirin and ah 23848
Article | Year |
---|---|
A specific thromboxane receptor blocking drug, AH23848, reduces platelet deposition on vascular grafts in man.
Topics: Aged; Aspirin; Biphenyl Compounds; Blood Vessel Prosthesis; Cell Survival; Dipyridamole; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Polyethylene Terephthalates; Receptors, Prostaglandin; Receptors, Thromboxane | 1990 |
A comparison of the effects of a thromboxane antagonist and cyclo-oxygenase inhibitor on platelet accumulation in arterial grafts.
Topics: Aorta; Aspirin; Biphenyl Compounds; Blood Platelets; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dipyridamole; Femoral Artery; Humans; Thrombosis; Thromboxanes; Vascular Surgical Procedures | 1987 |
1 other study(ies) available for aspirin and ah 23848
Article | Year |
---|---|
The effects of thromboxane antagonism on the transit time of platelets through the spleen.
Topics: Aged; Aspirin; Biphenyl Compounds; Blood Circulation; Blood Platelets; Dipyridamole; Double-Blind Method; Humans; Kinetics; Middle Aged; Platelet Aggregation; Random Allocation; Receptors, Prostaglandin; Receptors, Thromboxane; Spleen; Thromboxane A2 | 1985 |